Partial federal government shutdown
HCA does not anticipate any immediate impacts to our services or disruption to provider payments at this time. We will continue to monitor the situation and share updates if anything changes.
HCA does not anticipate any immediate impacts to our services or disruption to provider payments at this time. We will continue to monitor the situation and share updates if anything changes.
Use this page to find drug policies and request forms.
For information on billing and rates, the Apple Health preferred drug list, and expedited authorization codes, please visit the Prescription Drug Program on our provider billing guide and rates page.
Coverage for | Policies | Policy Number |
---|---|---|
ADHD/anti-narcolepsy |
|
|
Androgenic Agents |
|
|
Anorexiants/Anti-Obesity |
|
|
Antiasthmatic Monoclonal Antibodies |
|
|
Antibiotics |
|
|
Antidepressants |
|
|
Antidiabetics |
|
|
Antihemophilic |
|
|
Antihyperlipidemics |
|
|
Antiparasitics |
|
|
Antipsychotics |
|
|
Antivirals |
|
|
Atopic Dermatitis Agents |
|
|
Bone Density Regulators |
|
|
Brands with Biosimilars or A-rated Generics |
|
|
Cardiovascular Agents |
|
|
Chronic GI Motility Agents |
|
|
COVID-19 |
|
|
Corticosteroids |
|
|
Cystic Fibrosis Agents |
|
|
Cytokine and CAM Antagonists |
|
|
Dermatologics |
|
|
Endocrine and Metabolic Agents |
|
|
Gout Agents |
|
|
Growth Hormone Agents |
|
|
Hormone replacement |
|
|
Hematological Agents |
|
|
Hematopoietic Agents |
|
|
Immune Modulators |
|
|
Migraine Agents |
|
|
Movement Disorder Agents |
|
|
Multiple Sclerosis Agents |
|
|
Musculoskeletal Therapy Agents |
|
|
Neuromuscular Agents |
|
|
Oncology |
|
|
Opioids |
|
|
Ophthalmics |
|
|
Proton Pump Inhibitors (PPIs) |
|
|
Psychotherapeutic and Neurological Agents – MISC : Multiple Sclerosis Agents |
|
|
Psychotherapeutic and Neurological Agents – MISC : Transthyretin Amyloidosis Agents |
|
|
Pulmonary Arterial Hypertension (PAH) Agents |
|
|
Pulmonary Fibrosis Agents |
|
|
Respiratory Agents – MISC |
|
|
Sleep Disorder Agents |
|
|
Topical immunosuppressives |
|